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Abstract: The present investigation was aimed to study an anticonvulsant activity 
of aqueous extract of Desmodium triflorum (L.) DC., Fabaceae, in mice. Animal 
models of epilepsy namely the pentylenetetrazole, and maximal electroshock induced 
convulsion were used to evaluate the anticonvulsant effects of the extracts. The 
biochemical estimation was done by measuring the lipid peroxidation and reduced 
glutathione. In the pentylenetetrazole induced convulsion, aqueous extract of D. 
triflorum 800 mg/kg significant delayed the onset of convulsion, reduced the duration 
of convulsion (p<0.05) and reduced mortality. The aqueous extract of D. triflorum 
800 mg/kg dose reduced hind limb tonic extension phase of maximal electroshock 
induced convulsion induced convulsion in mice (p<0.05). The pretreated aqueous 
extract of D. triflorum showed significant inhibition of lipid peroxidation and 
increases the reduced glutathione level in mice brain tissue (p<0.001). The results 
revealed that D. triflorum possesses a significant dose dependent anticonvulsant 
activity.
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Introduction
 Epilepsy is a chronic brain disorder characterized 
by recurrent derangement of the nervous system due to 
sudden excessive disorderly discharge from the cerebral 
neurons (Maiha et al., 2009). It is the second most 
common neurological disorder with an annual incidence 
of 50 cases/100000 per year. Overall it accounts for 1% 
of the world’s burden of diseases, and the prevalence rate 
is reported at 2% (Vyawahare et al., 2007). Seizures are 
controlled in nearly 70% of patients with epilepsy, mostly 
through drugs effect on membrane ion channels or on 
gamma amino butyric acidergic (GABA) or glutamatergic 
transmission (Marjan et al., 2009). World Health 
Organization (WHO) estimated that approximately 80% 
people with epilepsy live in developing countries and most 
of them do not get adequate medical treatment (Reddy, 
2005). All the currently available antiepileptic drugs are 
synthetic molecules (Hema et al., 2009). In many patients, 
the presently available antiepileptic drugs (AED) such 
as phenobarbital, phenytoin, benzodiazepines, sodium 
valproate, carbamazepine, ethosuximide, trimethadione 
etc., are unable to control seizures effi ciently. Furthermore, 
the dose-related neurotoxicity and other side effects 
associated with established AED limit their clinical 
use. The newer AED like oxcarbazepine, vigabatrin, 
lamotrigine, gabapentin, felbamate etc., represent a real 
progress in the treatment of no responders or refractory 
patients. However, the problem of adverse effects has also 
not been circumvented completely and approximately 
30% of the patients continue to have seizures with current 
antiepileptic drugs therapy (Ezekiel et al., 2010). Hence, 
search should continue to develop newer, more effective, 
and safer neuroprotective agents for treatment of epilepsy. 
Medicinal plants used in traditional medicine for the 
treatment of epilepsy have been scientifi cally shown 
to posses promising anticonvulsant activities in animal 
models for screening for anticonvulsant activity (Wannang 
et al., 2008).
 Herbal medicine is still the mainstay of about 
75-80% of the world population, mainly in the developing 
countries, for primary health care because of better cultural 
acceptability, better compatibility with the human body 
and lesser side effects. However, the last few years have 
seen a major increase in their use in the developed world. 
Global estimates indicate that 80% of about 4 billion 
population cannot afford the products of the Western 
Pharmaceutical Industry and have to rely upon the use of 
traditional medicines which are mainly derived from plant 
material (Joy et al., 2001). Considering the great reliance 
on traditional medicinal plants for treatment of diseases 
and the potential for drug discovery; it becomes relevant 
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to search for potent, effective and relatively safe plant 
medicines.
 Of late, Desmodium triflorum (L.) DC., 
Fabaceae, is a perennial herb belonging to the family 
Papilionaceae (Kirtikar & Basu, 1980). The plant is 
available in all tropical countries. It contains hypaphorine 
(major alkaloid), N,N-dimethyltryptophan betain and 
choline (Ghosal et al., 1971). D. triflorum leaves contains 
total alkaloid, 0.01-0.015% and rare diholosylflavone, 
2-O-glucosylvitexin had been isolated from D. triflorum 
(Adinarayana & Syamsundar, 1982). It also contains 
ursolic acid, vitexin, genistin, fucosterol (Yoganarasimhan, 
1996). In traditional medicinal system, different parts of 
the plant have been mentioned to be useful in a variety 
of diseases. The leaves are used in diarrhoea, convulsions, 
anti-spasmodic, sympathomimetic, central nervous system 
stimulation, curare-mimetic activity and diuretic and as a 
galactagogue (Yoganarasimhan, 1996). The fresh leaves 
of the plant are applied to wounds and abscesses that are 
usually difficult to heal. The paste is sometimes applied to 
sores and itch. The fresh juice of the plant is often given 
to the children for coughs and asthma. The traditional use 
of the plant also recommends for use in dysentery and as 
a laxative (Adinarayana & Syamsundar, 1982), high fever 
(Samvatsar, 2004) and cure bone-fracture (Prusti & Behera, 
2007). Different extracts of D. triflorum exhibit analgesic 
and anti-inflammatory activities (Kawshik et al., 2005) and 
also possesses antioxidative and antiproliferative activities. 
(Mao et al., 2007; Lai et al., 2010). The antinociceptive 
activity of cold water extract of D. triflorum in rats (Daya et 
al., 2011) and antioxidant activities of phenolic components 
from various plants of Desmodium species were studied 
(Tsai et al., 2011). Recently Evaluation of anticonvulsant 
activity of ethanolic leaves extract of Desmodium 
triflorum in mice was studied and it possesses very good 
anticonvulsant activity (Gowda et al., 2012) however, only 
limited data are available concerning the anticonvulsant 
activity of this plant species hence the present work was 
undertaken to evaluate the anticonvulsant activity of an 
aqueous extract of D. triflorum leaves.
Material and Methods
Plant material
 Desmodium triflorum (L.) DC., Fabaceae, was 
collected from Gandhi Krushi Vignana Kendra (GKVK) 
Bangalore. The plant was identified and authenticated by 
Dr. Siddamallayya, National Ayurvedic Dietetics Research 
Institute Bangalore. The voucher specimen is preserved 
in our laboratory for future reference (Voucher No. Drug 
Authentication/SMPU/NADRI/BNG/2010-11/286).
Preparation of extract
 The leaves of the plant species collected were 
dried under shade for a period of four weeks. The dried 
plant material was milled to a fine powder using the 
commercial laboratory blender. Dried powder (300 g) was 
extracted in a Soxhlet extractor with ethanol for about 8-9 h 
at 45 oC. Extract was collected and dried using rotary flash 
evaporator at 40-45 oC and crude residue was collected. 
The yield was calculated as 30 g. The extract was stored 
in well closed glass container at 5 oC in refrigerator for 
further study.
Preliminary phytochemical analysis
 The extracts obtained were subjected to various 
chemical tests to detect the chemical constituents present 
in them (Trease & Evans, 1983; Khandelwal, 1996).
Animals
 Healthy Swiss albino mice of either sex (18-20 
g) were procured from the Central Animal Facilities of 
the Drug Testing Laboratory (DTL), Bangalore. Animals 
were housed at our Institute’s animal house facilities until 
they gained significant weight (25±5 g) suitable for the 
present investigation. The estrous cycle in female mice 
was observed normal. They were housed in hygienic cages 
(polypropylene cage) and maintained under standard 
laboratory conditions for one week before the experiments 
started and were kept in groups of six per cage at controlled 
temperature (22±2 oC) with 12 h light/dark cycle and 
humidity (50%). They received standard diet and water 
ad libitum. The animals were maintained in accordance 
with CPCSEA (Committee for the Purpose of Control 
and Supervision of Experimental Animals) guidelines for 
the care and use of laboratory animals. Approval for the 
experiment was obtained from the Institutional Animal 
Ethics Committee (IAEC), St. John’s Pharmacy College, 
Vijayanagar, Bangalore, letter No. IJAHSM/ IAEC/2010-
04.
Acute toxicity study
 Acute toxicity study for the aqueous and aqueous 
extract of D. triflorum was done according to the OECD 
guidelines No: 423 and low and high dose was selected 
for treatment. The aqueous extract (70.0%) of D. triflorum 
was administered orally in the escalating dosages, up to 
2000 mg/kg to different groups of rats (n=6, in each). The 
animals were observed for behavioral and physiological 
variations initially continuously for 4 h, followed by 4th 
hourly for 12 h and there after once daily for fourteen days. 
If toxic signs or lethality is not observed, then 1/5th, 1/10th 
and 1/20th part of the limit test dose were considered as test 
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doses for the present investigation.
Anticonvulsant screening method
 Pentylenetetrazole (PTZ) induced convulsion
 Animals were divided into IV groups, (n=6 mice 
of either sex in one group). Group I received respective 
vehicles (2% of Tween 80); group II was allotted for 
standard drug (diazepam 5 mg/kg) and group III, and 
IV (400 and 800 mg/kg body weight) received AEDT at 
different dose levels. All treatment and standard groups 
were statistically compared with vehicle groups. Vehicles, 
extracts are administered by oral route and standard 
drugs were administered by intra-peritoneal (i.p.) route. 
Mice were administered extracts for seven days and on 
the experimental day, PTZ 65 mg/kg was injected intra-
peritoneally to mice 45 min after vehicle or extracts 
and 30 min after the standard drug. Immediately after 
PTZ administration mice were observed for (1) onset 
of convulsions (elapsed time from PTZ injection until 
convulsion occurred), (2) duration of convulsion (number 
of mice showing convulsions) and (3) mortality for the 
duration of 30 min (Swinyard et al., 1952).
 Maximum electro shock (MES) induced 
convulsions
 The electroshock was applied via ear-clip 
electrodes separately to each mouse. The stimulus duration 
was 0.2 s and the current frequency 45 mA (60 Hz). Six 
mice of either sex in one group with a weight of 25±5 
g, mice were administered extracts for seven days and 
on the experimental day, test was started 60 min after 
administration of extracts and 30 min after standard drug 
(phenytoin 25 mg/kg i.p.). The animals were observed for 
the occurrence of tonic hind limb extension and mortality 
for duration of 15 min (Swinyard et al., 1952). The AEDT 
was administered to Group III and IV (400 and 800 mg/
kg body weight) where as group I and II received 2% of 
Tween 80 and Phenytoin 25 mg /kg i.p., respectively.
Biochemical estimation
 Tissue preparation
 Three groups were used (n=6). Group I animals 
(control) were administered 2% tween 80 (2.0 mL/kg, p.o.), 
Groups II and III animals were administered 400 and 800 
mg/kg of the AEDT orally. One hour after administration 
of the extract, PTZ (65 mg/kg) was injected i.p. to all the 
animals in Groups. On observing onset of convulsions, 
duration of seizure following the administration of PTZ, 
the animals (including control group) were sacrificed by 
decapitation and brain was removed, homogenized in 
0.9% NaCl by using Remi motor RQT-1.2.7A.
 Lipid peroxidation in brain
 Two milliliter of suspension medium was taken 
from 10% of tissue homogenate. To this, 2 mL of 30% of 
trichloroacetic acid was added, followed by 2 mL of 0.8% 
thiobarbituric acid (TBA) reagent. The tubes were covered 
with aluminum foil and kept in shaking water bath for half 
an hour at 80 oC after half an hour; the tubes were taken 
out and kept in ice cold water for half an hour. There were 
then centrifuged at 3000 x g for 15 min. The absorbance 
of the supernatant was read at 535 nm at room temperature 
against appropriate blank. Blank consist of 2 mL distilled 
water, 2 mL of 30% TCA and 2 mL of 0.8% TBA (Ohkawa 
et al., 1979). The content of malonaldehyde (MDA), 
expressed as n moles formed per milligram of protein in 
the tissue, was calculated using the formula:
Concentration = A x (V/E) x P
Where, A is the volume of solution, E is extinction 
coefficient (1.56 x 105m-1 cm-1) and P is the protein content 
of tissue calculated as milligram of protein per gram of 
tissue.
 Brain glutathione
 To 2 mL of 10% of homogenate, which was 
prepared in sodium chloride solution, 2.5 mL of 0.02M 
EDTA was added and shaken vigorously. To 2 mL of this 
mixture 4 mL of cold distilled water and 1 mL of 50% 
trichloroacetic acid were added and shaken for 10 min. 
Thereafter, the content were centrifuged at 3000 x g for 15 
min following centrifugation, 2 mL of the supernatant was 
mixed with 0.4M tris buffer (pH 8.9). The whole solution 
was mixed well and 0.1 mL of 0.01M DTNB was added, 
the absorbance was read within 5 min of addition of DTNB 
at 412 nm against reagent blank with no homogenate. For 
blank reading, the homogenate was substituted by 2 mL of 
distilled water (Sedlak & Lindsay, 1968). The amount of 
glutathione in tissue was expressed as μmol/g of tissue. 
μmol/mg wet tissue: [A/13600] x dilution factor x 1000.
Statistical analysis
 The data obtained by the various parameters was 
statistically evaluated by one way analysis of variance 
(ANOVA) followed by Dunneet’s Multiple Comparison 
Test by Graph Pad Prism software (GraphPad software Inc., 
Version 5.0.0). The mean values±SEM were calculated for 
each parameter. Level of significance was kept at p<0.05.
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Results
Preliminary phytochemical screening
 Phytochemical analysis of the aqueous extract 
of D. triflorum (AEDT) revealed the presence of 
alkaloids, proteins, flavonoids, phytosterol, saponin and 
tannins. However, the tests show that they do not contain 
carbohydrate, glycoside and fixed oil and fats.
Acute oral toxicity
 Acute oral toxicity studies revealed the non-toxic 
nature of the AEDT. Aqueous extract and aqueous extracts 
of D. triflorum did not show any sign and symptoms of 
toxicity and mortality up to 2000 mg/kg dose after fourteen 
days of study. This indicates that the extracts were found to 
be safe up to the dose levels studied. Since, all the animals 
survived at a dose of 2000 mg/kg body weight, the LD50 
of the extract will be >2000 mg/kg body weight. No major 
behavioral changes were observed during the period of 
study.
Anti-convulsant activity
 Effect of extracts on pentylenetetrazole induced 
convulsion 
 Pentylenetetrazole (65 mg/kg, i.p.) produced 
convulsion in all the animals used. All extracts groups 
compared with the control group. Mice pretreated 
with AEDT at the dose of 400 mg/kg p.o. not showed 
significant delay the onset of convulsion and duration of 
pentylenetetrazole induced seizures in mice and reduced 
mortality to 33.33%. Similarly a dose of 800 mg/kg p.o. 
of AEDT significantly delayed the onset of convulsion 
(p<0.05), reduced the duration of convulsion (p<0.05) and 
not found any mortality. The standard anti-epileptic drugs, 
Diazepam (5 mg/kg) blocked the clonic convulsions and 
mortality in mice against pentylenetetrazole induced 
convulsion (Table 1). 
 Effect of extracts on MES-induced convulsion
 The aqueous extract of D. triflorum caused 
significant decrease in the duration of hind limb tonic 
extension (HLTE) induced by maximal electroshock. The 
AEDT group was compared with the control group. AEDT 
dose of 400 mg/kg p.o. not showed significant reduction 
HLTE and reduced the mortality to 33.33%. AEDT dose of 
800 mg/kg p.o. significantly reduced the duration of HLTE 
(p<0.05) and no mortality was found against MES induced 
convulsion. Phenytoin (25 mg/kg i.p.) significantly 
reduced the duration of MES-induced HLTE (p<0.01) and 
completely prevented the various phases of convulsion 
induced by MES (Table 2).
Effect on brain lipid peroxidation 
 The effect of extract was showed significant 
inhibition of lipid peroxidation in mice brain tissue as 
compared to control group. The aqueous extract of D. 
triflorum 400 and 800 mg/kg p.o. dose showed significant 
(p<0.001) inhibition in malondialdehyde content compared 
to control group (Table 3).
Effects on reduced glutathion (GSH) level in mice brain 
tissue 
 The aqueous extract of D. triflorum 400 and 800 
mg/kg dose showed significant (p<0.01 and p<0.001) 
increases in brain GSH level compared to control (Table 
4).
Discussion
 The results of the present study demonstrate 
that aqueous extract of Desmodium triflorum (L.) DC., 
Fabaceae, possessed anticonvulsant activity. AEDT 
dose of 400 and 800 mg/kg significant delayed the onset 
of convulsion, significantly reduced the duration of 
convulsion and no mortality was found of the mice against 
pentylenetetrazole-induced convulsion. The standard 
anti-epileptic drug diazepam (5 mg/kg) completely 
antagonized the seizures produced by pentylenetetrazole. 
PTZ may be exerting convulsant effect by inhibiting the 
activity of GABA at GABA-A receptors (Vasconcelos et 
al., 2007). GABA is a major inhibitory neurotransmitter 
in the brain, and the inhibition of its neurotransmission 
has been thought to be the underlying factor in epilepsy 
Table 1. Effect aqueous extract of Desmodium triflorum on the pentylenetetrazole-induced convulsion in mice.
Experimental group Dose mg/kg b.w. Onset of clonic convulsion (min.)
Duration of 
convulsion (min) Mortality/used (%)
Control (2% tween 80) 2.0 mL/kg (p.o.) 1.08±0.10 4.79±1.03 3/6 (50%)
Standard (Diazepam) 5.0 mg/kg (i.p.) 0.00±0.00*** 0.00±0.00*** 0/6 (0%)
AEDT 400 (p.o.) 1.88±0.48 2.64±0.67 2/6 (33.33%)
AEDT 800 (p.o.) 3.26±0.50* 1.99±0.54* 0/6 (0%)
All values expressed as mean±SEM; n=6 mice in each group, by one-way ANOVA followed by Dunneet’s Multiple Comparison Test (compared with 
control group) *p<0.05, **p<0.01 and ***p<0.001.
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(Silambujanaki et al., 2010). The enhancement of the 
GABAergic neurotransmission is reported to antagonize 
seizures, while the inhibition of the neurotransmission 
promotes seizures (Amabeokua et al., 2007). The protection 
of mice against PTZ-induced seizures by the standard 
anticonvulsant drugs, phenobarbitone and diazepam is 
expected, since various authors have shown that they 
exert their anticonvulsant activities by enhancing GABA-
mediated inhibition (Mahomed & Ojewole, 2006).
 The findings of the present study, therefore, 
tend to suggest that D. triflorum aqueous extracts have 
anticonvulsant activity might have inhibited and/or 
attenuated PTZ -induced seizures of the mice used by 
enhancing, or in some ways interfering with GABAergic 
neurotransmission. 
 The maximal electroshock induced convulsion 
in animals represents grandmal type of epilepsy. The 
tonic extensor phase is selectively abolished by the drugs 
effective in generalized tonic clonic seizure. The most 
outstanding action of phenytoin showed abolition of tonic 
extensor phase of MES seizure many drugs that increase 
the brain content of Gama amino butyric acid (GABA) 
have exhibited anticonvulsant activity against seizures 
induced by MES (Manigauha et al., 2009). There are 
numerous molecular mechanisms through which drugs 
can block seizure spread and or elevate seizure threshold. 
Indeed, attempts to correlate the anticonvulsant profiles 
of antiepileptic drugs with specific mechanisms of action 
reveal certain notable trends. MES induced tonic extension 
can be blocked by drugs such as phenytoin, carbamazepine, 
lamotrigine, felbamate and valproate that inhibit voltage-
dependent Na+ channels (Ambavadea et al., 2009).
 The extract caused significant decrease in the 
duration of hind limb tonic extension (HLTE) induced by 
maximal electroshock. AEDT dose of 400 and 800 mg/kg 
significantly reduced the duration of HLTE and reduced 
the mortality. The standard antiepileptic drug phenytoin 
(25 mg/kg i.p.) significantly reduced the duration of HLTE 
of MES-induced convulsion and completely abolished the 
various phases of convulsion. Reduction in the duration 
of tonic hind limb extension of MES induced convulsion 
indicated AEDT has anticonvulsant activity. Free radicals 
have been suggested to be the most likely candidates 
responsible for producing the neuronal changes mediating 
Table 2. Anticonvulsant effect aqueous extract of Desmodium triflorum on the MES-induced convulsion in mice.
Experimental group Dose in mg/kg b.w.
Time in seconds of various phase of convulsion
Mortality/ used 
(%)Flexion Extension HLTE Stupor Recovery
Control (2% tween 80) 2.0 mL/kg 
(p.o.) 17.33±2.24 13.83±1.07 142.5±7.50 185.0±5.00 4/6 (66.66%)
Standard enytoin) 25 mg/kg (i.p.) 9.00±1.36** - - 11.50±1.17 0/6 (0.0%)
AEDT 400 (p.o.) 9.50±0.76** 9.50±0.76 125.5±9.32 165.0±5.40 2/6 (33.33%)
AEDT 800 (p.o.) 8.83±1.57** 9.66±0.66* 63.60±21.04 118.3±9.38* 0/6 (0.0%)
All values expressed as mean±SEM; n=6 mice in each group, by one-way ANOVA followed by Dunneet’s Multiple Comparison Test (compared with 
control group) *p<0.05, **p<0.01 and ***p<0.001.
Table 3. Effect aqueous extract of Desmodium triflorum on brain lipid peroxidation.
Experimental group Dose mg/kg b.w. Lipid peroxidation n moles of MDA/mg of protein Decrease in MDA (%)
Control (2% tween 80) + PTZ 2.0 mL/kg (p.o.) 0.558± 0.019 0.00
AEDT+PTZ 400 (p.o.) 0.326± 0.011*** 41.57
AEDT+PTZ 800 (p.o.) 0.310±0.019*** 44.45
All values expressed as mean±SEM; n=6 mice in each group, by one-way ANOVA followed by Dunneet’s Multiple Comparison Test (compared with 
control group) *p<0.05, **p<0.01, and ***p<0.001.
Table 4. Effect of aqueous extract of Desmodium triflorum on glutathione (GSH) level in mice brain tissue.
Experimental group Dose mg/kg b.w.
Glutathione
Increase in GSH (%)
μmoles/mg of  protein
Control (2% tween 80) + PTZ 2.0 mL/kg (p.o.) 9.95±0.16 0.00
AEDT+PTZ 400 (p.o.) 10.82±0.17** 8.74
AEDT+PTZ 800 (p.o.) 13.07±0.18*** 31.35
All values expressed as mean±SEM; n=6 mice in each group, by one-way ANOVA followed by Dunneet’s Multiple Comparison Test (compared with 
control group) *p<0.05, **p<0.01 and ***p<0.001.
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the behavioral deficits in neurodegenerative. Antioxidants 
are effective in rodent models of epilepsy, stroke and 
Alzheimer’s disease (Golechha et al., 2010). Therefore 
the effect of AEDT on oxidative stress in PTZ induced 
convulsion was also evaluated. Mice pretreated with AEDT 
400 and 800 mg/kg dose showed significant decrease in 
malondialdehyde content in mice brain compared with the 
control group. Glutathione is an endogenous antioxidant 
form within the free radicals and prevents the generation 
of hydroxyl radicals, the most toxic form of free radicals 
(Golechha et al., 2010). The decreased the level of reduced 
glutathione in control group mice seen in the present study 
indicates that there was an increased generation of free 
radicals and that the reduced glutathione was depleted 
during process of combating oxidative stress (Schulz et al., 
2000). AEDT 400 and 800 mg/kg dose showed significant 
increases the GSH level in mice brain. The decreases in 
MDA and increase in the glutathione level in AEDT+PTZ 
mice indicates that AEDT exerted good antioxidant effect. 
Several studies also indicates that on medicinal plants 
antioxidant activities are due to the presence of polyphenols 
and flavonoids (Asuntha et al., 2010).
 Phytochemical studies indicates the presence 
of phenolic compounds and flavonoids in D. triflorum. 
Phytochemical evaluation of D. triflorum revealed the 
presence of alkaloid, steroid, flavonoids, saponin, proteins 
and tannins in AEDT. Various phytochemicals have been 
reported to possess CNS activities. The anticonvulsant 
activity was attributed, alkaloids (Taesotikul et al., 1998), 
essential oils (Dallmeier & Carlini, 1981), flavonoids 
(Asl et al., 2007), triterpenic steroids and triterpenoidal 
saponins are reported to possess anticonvulsant activity 
in some experimental seizure models such as MES and 
PTZ (Chauhan et al., 1988; Kasture et al., 2002). It is also 
found that many flavonoids could act as benzodiazepine- 
like molecules in the central nervous system and modulate 
GABA-generated chloride currents in animal models of 
anxiety, sedation and convulsion (Asl et al., 2007). In the 
present investigation, the anticonvulsant activity can be 
attributed to the presence of alkaloids, steroids, flavonoids, 
tannins and saponin in aqueous extract of D. triflorum.
Conclusion
 The aqueous leaf extract of Desmodium 
triflorum (L.) DC., Asteraceae, demonstrated potential 
anticonvulsant properties and less toxicity in the 
experimental animals at the doses used. However, 
further studies still needed to be carried on exposure 
of the extract to humans, and its use in folk medicine 
for seizure control should be accompanied by regular 
assessment of level of consciousness and blood 
pressure. 
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